These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31773164)

  • 21. Azole cross-resistance in Aspergillus fumigatus.
    Mosquera J; Denning DW
    Antimicrob Agents Chemother; 2002 Feb; 46(2):556-7. PubMed ID: 11796377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of Prototheca zopfii genotypes 1 and 2.
    Sobukawa H; Kano R; Ito T; Onozaki M; Makimura K; Hasegawa A; Kamata H
    Med Mycol; 2011 Feb; 49(2):222-4. PubMed ID: 20795764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated Protothecosis Due to Prototheca zopfii and Literature Review.
    Chen F; Saab-Chalhoub M; Tao J; Harrington AT; Albarillo FS; Crone AS; Clark NM; Speiser JJ
    Am J Dermatopathol; 2023 Apr; 45(4):237-241. PubMed ID: 36805355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
    Minassian B; Huczko E; Washo T; Bonner D; Fung-Tomc J
    Clin Microbiol Infect; 2003 Dec; 9(12):1250-2. PubMed ID: 14686996
    [No Abstract]   [Full Text] [Related]  

  • 25. Emergence of Fungal-Like Organisms: Prototheca.
    Kano R
    Mycopathologia; 2020 Oct; 185(5):747-754. PubMed ID: 31401758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Algicidal effect of blue light on pathogenic Prototheca species.
    Dos Anjos C; Sellera FP; Gargano RG; Lincopan N; Pogliani FC; Ribeiro MG; Jagielski T; Sabino CP
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():210-213. PubMed ID: 30965146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual case of granulomatous lymphadenitis due to Prototheca zopfii var. portoricensis in an immunocompetent man in China.
    Zhang Q; Weng X; Li L; Zhu L; Yu S; Chen S; Xiang Y; Wan H; Ran Y; Kang K
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e32-5. PubMed ID: 20117953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of Cryptococcus neoformans (formerly: Cryptococcus grubii) to Ravuconazole.
    Kano R; Sugita T; Kamata H
    Med Mycol J; 2020; 61(1):11-13. PubMed ID: 32115444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protothecosis in patients with cancer: case series and literature review.
    Torres HA; Bodey GP; Tarrand JJ; Kontoyiannis DP
    Clin Microbiol Infect; 2003 Aug; 9(8):786-92. PubMed ID: 14616698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Mello E; Posteraro B; Vella A; De Carolis E; Torelli R; D'Inzeo T; Verweij PE; Sanguinetti M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of cutaneous protothecosis mimics eczema.
    Zhang Q; Li L; Yuli K; Zhao Y; Zhu J; Zhu M
    Mycopathologia; 2015 Feb; 179(1-2):163-6. PubMed ID: 25200680
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Zheng H; Song N; Mei H; Dong J; Li D; Li X; Liu W
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points].
    Pemán J; Cantón E; Calabuig E; Bosch M; Valentí A; Viudes A; Gobernado M
    Rev Esp Quimioter; 2006 Mar; 19(1):21-33. PubMed ID: 16688288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
    Pfaller MA; Diekema DJ; Messer SA; Boyken L; Huynh H; Hollis RJ
    J Clin Microbiol; 2002 May; 40(5):1694-7. PubMed ID: 11980944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Disseminated Protothecosis: The Skin is the "Window"?
    Wang X; Ran Y; Jia S; Ahmed S; Long X; Jiang Y; Jiang Y
    Front Immunol; 2022; 13():880196. PubMed ID: 35774787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistopathology of Prototheca wickerhamii in cutaneous lesions of protothecosis.
    Kano R; Sobukawa H; Suzuki M; Hiruma M; Shibuya K; Hasegawa A; Kamata H
    Med Mycol J; 2014; 55(1):E29-32. PubMed ID: 24682095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of conventional antifungal drugs and natural essences against the yeast-like alga Prototheca.
    Tortorano AM; Prigitano A; Dho G; Piccinini R; Daprà V; Viviani MA
    J Antimicrob Chemother; 2008 Jun; 61(6):1312-4. PubMed ID: 18339634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Susceptibility Profiling of
    Proskurnicka A; Żupnik K; Bakuła Z; Iskra M; Rösler U; Jagielski T
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0162722. PubMed ID: 36943065
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
    Laverdiere M; Hoban D; Restieri C; Habel F
    J Antimicrob Chemother; 2002 Jul; 50(1):119-23. PubMed ID: 12096017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.